High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis
Phase 2
Completed
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-10-01
- Lead Sponsor
- Temple University
- Registration Number
- NCT00002810
- Locations
- 🇺🇸
Fox Chase-Temple Cancer Center CCOP Research Base, Philadelphia, Pennsylvania, United States
Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
Phase 2
Completed
- Conditions
- Lymphoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-10-01
- Lead Sponsor
- Temple University
- Registration Number
- NCT00002521
- Locations
- 🇺🇸
Fox Chase - Temple Cancer Center, Philadelphia, Pennsylvania, United States
Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
Phase 2
Completed
- Conditions
- LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-10-01
- Lead Sponsor
- Temple University
- Target Recruit Count
- 10
- Registration Number
- NCT00002809
- Locations
- 🇺🇸
Fox Chase-Temple Cancer Center, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath